Brief: NlS Pharmaceutics Ltd Regains Full Compliance With Nasdaq Listing Requirements
28/10/2024 12:05
Oct 28 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS LTD REGAINS FULL COMPLIANCE WITH NASDAQ
LISTING REQUIREMENTS
Source text: ID:
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing